Showing results (21-30 of 512) with videos related to
Sort By:
Pageof 52
Neurosci|November 1, 2024
Cognitive Impairment in Multiple Sclerosis: An Update on Assessment and ManagementEmilio Portaccio, Maria Pia AmatoQuality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 29, 2011
Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II)Francesco Patti, Maria Pia Amato, Maria Trojano, et al.BMC Neurology|October 18, 2011
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) studyStefano Bastianello, Elisabetta Giugni, Maria Pia Amato, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 3, 2020
Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosisMaria Pia Amato, Benedetta Goretti, Vincenzo Brescia Morra, et al.Journal of Neurology|April 13, 2006
Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohortMaria Pia Amato, Valentina Zipoli, Benedetta Goretti, et al.Therapeutic Advances in Neurological Disorders|July 12, 2023
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4Diego Centonze, Maria Pia Amato, Vincenzo Brescia Morra, et al.Plos One|May 5, 2012
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational studyPietro Iaffaldano, Rosa Gemma Viterbo, Damiano Paolicelli, et al.Journal of Neurology|January 13, 2005
European validation of a standardized clinical description of multiple sclerosisMaria Pia Amato, Jerome Grimaud, Iuliana Achiti, et al.Journal of the Neurological Sciences|April 29, 2006
Are there protective treatments for cognitive decline in MS?Maria Pia Amato, Emilio Portaccio, Valentina ZipoliExpert Review of Neurotherapeutics|March 5, 2019
Identifying risk factors for cognitive issues in multiple sclerosisMaria Pia Amato, Elio Prestipino, Angelo BellinviaPageof 52